We leveraged a long-acting antiretroviral therapy program infrastructure in the US South to vaccinate 32 of 39 (82%) eligible persons with HIV against hepatitis B virus. Novel interprofessional programmatic synergy may facilitate hepatitis B virus vaccine uptake in a population uniquely at risk in the era of 2-drug and injectable antiretroviral therapy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11879927 | PMC |
| http://dx.doi.org/10.1093/ofid/ofaf096 | DOI Listing |
Publication Analysis
Top Keywords
hepatitis virus
12
antiretroviral therapy
12
virus vaccine
8
vaccine uptake
8
long-acting antiretroviral
8
programmatic synergy
8
enhancing hepatitis
4
uptake immunity
4
immunity long-acting
4
therapy programmatic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!